Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002187275 | SCV002343544 | likely benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2024-07-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002331683 | SCV002631064 | likely benign | Inborn genetic diseases | 2017-09-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004704697 | SCV005209539 | likely benign | not provided | criteria provided, single submitter | not provided |